HK25884A - Pyridopyrimidines - Google Patents
PyridopyrimidinesInfo
- Publication number
- HK25884A HK25884A HK258/84A HK25884A HK25884A HK 25884 A HK25884 A HK 25884A HK 258/84 A HK258/84 A HK 258/84A HK 25884 A HK25884 A HK 25884A HK 25884 A HK25884 A HK 25884A
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyridopyrimidines
- tetrazol
- pyrido
- pyrimidin
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/800,264 US4122274A (en) | 1977-05-25 | 1977-05-25 | 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK25884A true HK25884A (en) | 1984-03-30 |
Family
ID=25177928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK258/84A HK25884A (en) | 1977-05-25 | 1984-03-22 | Pyridopyrimidines |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4122274A (xx) |
| JP (1) | JPS6050197B2 (xx) |
| AT (1) | AT365187B (xx) |
| AU (1) | AU521211B2 (xx) |
| BE (1) | BE867295A (xx) |
| CA (1) | CA1098520A (xx) |
| CH (1) | CH642656A5 (xx) |
| CY (1) | CY1218A (xx) |
| DE (1) | DE2822544A1 (xx) |
| DK (1) | DK160279C (xx) |
| FI (1) | FI64594C (xx) |
| FR (1) | FR2401159A1 (xx) |
| GB (1) | GB1596476A (xx) |
| GR (1) | GR71887B (xx) |
| HK (1) | HK25884A (xx) |
| IE (1) | IE46849B1 (xx) |
| IT (1) | IT1105040B (xx) |
| KE (1) | KE3357A (xx) |
| LU (1) | LU79694A1 (xx) |
| MY (1) | MY8500305A (xx) |
| NL (1) | NL190702C (xx) |
| NO (1) | NO150361C (xx) |
| SE (1) | SE437830B (xx) |
| SG (1) | SG73383G (xx) |
| YU (2) | YU42163B (xx) |
| ZA (1) | ZA782816B (xx) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
| US4495189A (en) * | 1975-11-27 | 1985-01-22 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | Condensed pyrimidines |
| HU180439B (en) * | 1977-12-29 | 1983-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing 9-amino-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives |
| US4192944A (en) * | 1978-04-03 | 1980-03-11 | Bristol-Myers Company | Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents |
| US4223031A (en) * | 1978-05-05 | 1980-09-16 | Mead Johnson & Company | Azolopyrimidinones |
| US4491587A (en) * | 1978-05-05 | 1985-01-01 | Mead Johnson & Company | Tetrazole derivatives |
| US4282360A (en) * | 1979-10-12 | 1981-08-04 | Hoffmann-La Roche Inc. | 7-Methylthio or methylsulfinyl-5-oxo-5H-thiazolo[2,3-b]quinazoline-2-carboxylic acid |
| US4419357A (en) * | 1982-01-18 | 1983-12-06 | The Dow Chemical Company | 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones |
| US4476130A (en) * | 1982-09-09 | 1984-10-09 | Riker Laboratories, Inc. | 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity |
| US4507477A (en) * | 1982-09-09 | 1985-03-26 | Riker Laboratories, Inc. | Process for tetrazolyl-pyrimidinone derivatives |
| US4474953A (en) * | 1982-09-09 | 1984-10-02 | Riker Laboratories, Inc. | Process and intermediates for the preparation of 3(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-ones |
| US4457932A (en) * | 1983-07-22 | 1984-07-03 | Bristol-Myers Company | Anti-ulcer agents |
| AU588917B2 (en) * | 1985-09-25 | 1989-09-28 | Shionogi & Co., Ltd. | 9-(substituted thio)-4h-pryido(1,2-a) pyrimidin-4-one derivatives |
| JPS63183581A (ja) * | 1985-10-03 | 1988-07-28 | Tokyo Tanabe Co Ltd | ピリド〔１，２−ａ〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬 |
| JPS62242682A (ja) * | 1986-04-16 | 1987-10-23 | Tokyo Tanabe Co Ltd | 新規なピリド［１，２―ａ］ピリミジン誘導体及びその製造法 |
| JP2504788B2 (ja) * | 1987-11-10 | 1996-06-05 | 東京田辺製薬株式会社 | ９−メチル−３−（１Ｈ−テトラゾ―ル−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンカリウム塩の水性製剤 |
| WO1989006130A1 (en) * | 1987-12-25 | 1989-07-13 | Santen Pharmaceutical Co., Ltd. | Antiallergic eye drop |
| CA2010336C (en) * | 1989-02-27 | 1996-11-19 | Atsunori Sano | Process for producing pyrido[1,2-a]pyrimidine derivative |
| HU209793B (en) * | 1990-09-25 | 1994-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same |
| EP0653209A4 (en) | 1992-07-30 | 1997-03-19 | Tokyo Tanabe Co | REMEDY FOR INFLAMMATORY BOWEL DISORDERS. |
| US5527802A (en) * | 1992-10-01 | 1996-06-18 | Bristol-Myers Squibb Company | New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones |
| JPH0892093A (ja) * | 1994-11-10 | 1996-04-09 | Tokyo Tanabe Co Ltd | ９−メチル−３−（１Ｈ−テトラゾール−５−イル）−４Ｈ−ピリド［１，２−ａ］ピリミジン−４−オンの水性製剤 |
| JP4171303B2 (ja) * | 2001-02-26 | 2008-10-22 | 田辺三菱製薬株式会社 | 腎疾患・腎不全の予防剤及び／又は治療剤 |
| ITMI20011764A1 (it) | 2001-08-10 | 2003-02-10 | Dinamite Dipharma Spa | Metodo per l'ottenimento del pemirolast ad elevata purezza |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
| SI2120919T1 (sl) * | 2006-12-18 | 2012-12-31 | Cardoz Ab | Nova kombinacija za uporabo pri zdravljenju vnetnih obolenj |
| ES2395120T3 (es) * | 2006-12-20 | 2013-02-08 | Cardoz Ab | Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios |
| WO2009007675A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist |
| WO2009007679A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist |
| US20100184783A1 (en) * | 2007-07-11 | 2010-07-22 | Johan Raud | Combination for use in the treatment of inflammatory atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist |
| CA2720547A1 (en) * | 2008-04-07 | 2009-10-15 | Cardoz Ab | New combination for use in the treatment of inflammatory disorders |
| WO2010146341A2 (en) * | 2009-06-16 | 2010-12-23 | Cardoz Ab | New crystalline form of pemirolast |
| USD661900S1 (en) | 2010-02-22 | 2012-06-19 | Bajer Design & Marketing, Inc. | Collapsible structure |
| CA2863874C (en) | 2012-02-10 | 2021-02-16 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| EP2819519B1 (en) | 2012-03-01 | 2019-10-23 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| BR112014023483B1 (pt) | 2012-03-23 | 2022-05-10 | Ptc Therapeutics, Inc | Composto e seu uso, composição farmacêutica e seu uso |
| US10195202B2 (en) | 2013-12-19 | 2019-02-05 | Ptc Therapeutics, Inc. | Methods for modulating the amount of RNA transcripts |
| WO2016063085A1 (en) | 2014-10-23 | 2016-04-28 | Rspr Pharma Ab | Use of pemirolast in the treatment of acute asthma |
| WO2016102941A1 (en) | 2014-12-22 | 2016-06-30 | Rspr Pharma Ab | New combination of pemirolast and montelukast |
| CN107635999B (zh) * | 2015-05-20 | 2020-09-25 | 豪夫迈·罗氏有限公司 | 用于治疗脊髓性肌萎缩的化合物 |
| WO2016196386A1 (en) | 2015-05-30 | 2016-12-08 | Ptc Therapeutics, Inc. | Methods for modulating rna splicing |
| GB201518831D0 (en) | 2015-10-23 | 2015-12-09 | Rspr Pharma Ab | New use |
| CN113750101A (zh) | 2015-12-10 | 2021-12-07 | Ptc医疗公司 | 用于治疗亨廷顿病的方法 |
| GB201601138D0 (en) * | 2016-01-21 | 2016-03-09 | Rspr Pharma Ab | New use |
| CN110352007A (zh) | 2016-11-28 | 2019-10-18 | Ptc医疗公司 | 用于调节rna剪接的方法 |
| CA3066224A1 (en) | 2017-06-05 | 2018-12-13 | Ptc Therapeutics Inc. | Compounds for treating huntington's disease |
| KR20200017476A (ko) | 2017-06-14 | 2020-02-18 | 피티씨 테라퓨틱스, 인크. | Rna 스플라이싱의 변경 방법 |
| WO2019005980A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | METHODS OF TREATING HUNTINGTON'S DISEASE |
| BR112019027719A2 (pt) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics, Inc. | métodos para tratar a doença de huntington |
| CA3094703A1 (en) | 2018-03-27 | 2019-10-03 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| HUE068060T2 (hu) | 2018-06-27 | 2024-12-28 | Ptc Therapeutics Inc | Heterociklikus és heteroaril vegyületek Huntington-kór kezelésére |
| BR112020026534A2 (pt) | 2018-06-27 | 2021-03-23 | Ptc Therapeutics, Inc. | Compostos de heteroarila para o tratamento da doença de huntington |
| WO2020005882A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3072485A (en) * | 1960-08-24 | 1963-01-08 | Eastman Kodak Co | Optically sensitized azido polymers for photomechanical resist compositions |
| AT294107B (de) * | 1966-11-02 | 1971-11-10 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen |
| US3960847A (en) * | 1972-04-17 | 1976-06-01 | E. R. Squibb & Sons, Inc. | 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof |
| US3929787A (en) * | 1974-04-22 | 1975-12-30 | Squibb & Sons Inc | 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones |
| US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
| US4017625A (en) * | 1975-08-01 | 1977-04-12 | Pfizer Inc. | Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor |
| US4012387A (en) * | 1975-09-18 | 1977-03-15 | Warner-Lambert Company | Benzo-[g]pyrido[2,1-b]quinazolinones |
-
1977
- 1977-05-25 US US05/800,264 patent/US4122274A/en not_active Expired - Lifetime
-
1978
- 1978-05-15 GR GR56238A patent/GR71887B/el unknown
- 1978-05-17 ZA ZA00782816A patent/ZA782816B/xx unknown
- 1978-05-19 BE BE187888A patent/BE867295A/xx not_active IP Right Cessation
- 1978-05-19 CA CA303,794A patent/CA1098520A/en not_active Expired
- 1978-05-22 AU AU36319/78A patent/AU521211B2/en not_active Expired
- 1978-05-22 FI FI781614A patent/FI64594C/fi not_active IP Right Cessation
- 1978-05-22 NL NL7805534A patent/NL190702C/xx not_active IP Right Cessation
- 1978-05-23 AT AT0373278A patent/AT365187B/de not_active IP Right Cessation
- 1978-05-23 DE DE19782822544 patent/DE2822544A1/de active Granted
- 1978-05-23 DK DK228878A patent/DK160279C/da active
- 1978-05-23 NO NO781786A patent/NO150361C/no unknown
- 1978-05-23 LU LU79694A patent/LU79694A1/xx unknown
- 1978-05-24 IE IE1036/78A patent/IE46849B1/en not_active IP Right Cessation
- 1978-05-24 SE SE7805954A patent/SE437830B/sv not_active IP Right Cessation
- 1978-05-24 YU YU1236/78A patent/YU42163B/xx unknown
- 1978-05-24 IT IT49523/78A patent/IT1105040B/it active
- 1978-05-24 GB GB22090/78A patent/GB1596476A/en not_active Expired
- 1978-05-24 FR FR7815398A patent/FR2401159A1/fr active Granted
- 1978-05-24 CY CY1218A patent/CY1218A/en unknown
- 1978-05-25 CH CH572378A patent/CH642656A5/de not_active IP Right Cessation
- 1978-05-25 JP JP53061768A patent/JPS6050197B2/ja not_active Expired
-
1982
- 1982-10-15 YU YU2330/82A patent/YU44212B/xx unknown
-
1983
- 1983-11-25 SG SG733/83A patent/SG73383G/en unknown
- 1983-12-15 KE KE3357A patent/KE3357A/xx unknown
-
1984
- 1984-03-22 HK HK258/84A patent/HK25884A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY305/85A patent/MY8500305A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK25884A (en) | Pyridopyrimidines | |
| CA2209487A1 (en) | Imidazo[4,5-c]quinoline amines | |
| IE781878L (en) | Imidazole derivatives | |
| AU6842981A (en) | Novel 3-(1-piperidinyialkyl)-4h-pyrido (1,2-a)- pyrimidin-4-one derivatives | |
| IE46232L (en) | PYRIDO (2,1-b) QUINAZOLINONES | |
| NO874904D0 (no) | Fremgangsmaate for fremstilling av nye imidazopyridin-forbindelser. | |
| AU513636B2 (en) | Penicillanic acid 1,1-dioxides as beta-lactamase inhibitors | |
| NO884231D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridin-derivater. | |
| IE780515L (en) | Morphine derivatives | |
| NO151287C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidinderivater | |
| IL55338A (en) | Analgesic pharmaceutical compositions containing 2,3-dialkylpyrido(1,2-a)pyrimidine-4-one derivatives,some new such compounds and their preparation | |
| DE68929368D1 (de) | Cephemderivate und Verfahren zu ihrer Herstellung | |
| FI891200A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 5-substituoitujen /4,5-c/imidatsopyridiinijohdannaisten valmistamiseksi | |
| DE3863625D1 (de) | Waessrige zubereitung des 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)-pyrimidin-4-one-kaliumsalzes. | |
| NO147564C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 5-benzyol-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karboksylsyrederivater | |
| AU3436578A (en) | Heterocyclic substituted imidazo (1, 2-a)pyridines | |
| PH27332A (en) | (2-Imidazoline-2yl) thieno-and furo[2,3-b] and [3,2-b] pyridines and intermediates for the preparation thereof and use of said compounds as herbicidal agents | |
| IE790950L (en) | Pyridopyrimidones plastics web with a three-dimension microstructure | |
| IE44154L (en) | 1,3,8-triazaspiro(4,5) decan-4-one derivatives | |
| NZ225659A (en) | Pharmaceutical compositions containing pyrrolidin-1-yl-6-fluoro-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid derivatives | |
| IE780514L (en) | Morphine derivatives | |
| CA1271748C (en) | BENZAZEPINE DERIVATIVES | |
| IE44989L (en) | INDOLO [3,2,1-d,e] [1,5] NAPHTHYRIDINE DERIVATIVES | |
| AU521096B2 (en) | Pyrido [2, 1-b] quinazoline derivatives | |
| AU2697677A (en) | 5-furoyl and 5-thenoyl pyrrolo[1,2-a] pyrrole-carboxylic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |